Nearly 1,000 GLP-1 Lawsuits Allege Failure-to-Warn Vision Loss
Mass tort litigation against Novo Nordisk and Eli Lilly is escalating, with nearly 1,000 cases in New Jersey alone alleging the companies failed to warn patients about NAION risk.
Legal entity
Cleveland Clinic
CompanyEvery one of those 1 sits in a single category, court-decisions. American Academy of Ophthalmology is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Cleveland Clinic appears in 1 tracked Legal story from September 24, 2026.
Last mentioned: 3d ago
Entity pulse
Recent coverage · Cleveland Clinic
1 story
avg impact
0% positive
100% negative
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
What the coverage shows about Cleveland Clinic
Every one of those 1 sits in a single category, court-decisions. American Academy of Ophthalmology is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Cleveland Clinic appears in 1 tracked Legal story from September 24, 2026.
- Stories tracked
- 1
- Sources per story
- 2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Cleveland Clinic. Shared-story counts are live from our verified record — not editorial picks.
Timeline
-
Civil lawsuit against Novo Nordisk reported
The Wall Street Journal reported a civil lawsuit filed against Novo Nordisk by patients who developed NAION after taking Wegovy or Ozempic; similar cases against Eli Lilly are pending.
-
AAO issues statement on GLP-1s and vision loss
The American Academy of Ophthalmology released a news release urging clinicians and patients to make informed choices about GLP-1 use after studies linked the drugs to vision loss.
-
Boston medical center issues safety alert
Researchers at a Boston medical facility sent a safety alert flagging a possible connection between GLP-1 medications and NAION.
Stories mentioning Cleveland Clinic 1
Cleveland Clinic is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.